During the past decade, Buddhist Tzu Chi General Hospital conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 11 clinical trials were completed, i.e. on average, 39.3% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 2 clinical trials were completed. i.e. 15.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Buddhist Tzu Chi General Hospital" #1 sponsor was "Buddhist Tzu Chi General Hospital" with 31 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Gwo Xi Stem Cell Applied Technology Co., Ltd." with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Allergan" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Buddhist Tzu Chi General Hospital" #1 collaborator was "Ministry of Science and Technology, Taiwan" with 2 trials as a collaborator, "Beijing Tiantan Hospital" with 1 trials as a collaborator, "Buddhist Tzu Chi General Hospital" with 1 trials as a collaborator, "Chang-Hua Hospital" with 1 trials as a collaborator and "Chest Hospital, Ministry of Health and Welfare, Taiwan" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Buddhist Tzu Chi General Hospital" are "Interstitial Cystitis" (4 trials), "Helicobacter Pylori Infection" (3 trials), "Overactive Bladder" (3 trials), "Fatigue" (2 trials) and "Overactive Bladder Syndrome" (2 trials). Many other conditions were trialed in "Buddhist Tzu Chi General Hospital" in a lesser frequency.

Most popular intervention types in "Buddhist Tzu Chi General Hospital" are "Drug" (36 trials), "Procedure" (3 trials), "Behavioral" (2 trials), "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Botulinum toxin A" (4 trials), "Normal saline instillation" (3 trials), "Placebo" (3 trials), "Normal saline" (2 trials) and "10RAC+acetylcystein" (1 trials). Other intervention names were less common.

The vast majority of trials in "Buddhist Tzu Chi General Hospital" are 47 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Buddhist Tzu Chi General Hospital". undefined are not yet recruiting, 7 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Buddhist Tzu Chi General Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Buddhist Tzu Chi General Hospital, 3 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 12 trials that are defined as “Not Applicable".